ALLEGRA D-12 HOUR- fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, extended release Stati Uniti - Ingliż - NLM (National Library of Medicine)

allegra d-12 hour- fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, extended release

physicians total care, inc. - fexofenadine hydrochloride (unii: 2s068b75zu) (fexofenadine - unii:e6582loh6v), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - fexofenadine hydrochloride 60 mg - allegra-d 12 hour extended-release tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years of age and older. symptoms treated effectively include sneezing, rhinorrhea, itchy nose/palate/ and/or throat, itchy/watery/red eyes, and nasal congestion. allegra-d 12 hour should be administered when both the antihistaminic properties of fexofenadine hydrochloride and the nasal decongestant properties of pseudoephedrine hydrochloride are desired (see clinical pharmacology). allegra-d 12 hour is contraindicated in patients with known hypersensitivity to any of its ingredients. due to its pseudoephedrine component, allegra-d 12 hour is contraindicated in patients with narrow-angle glaucoma or urinary retention, and in patients receiving monoamine oxidase (mao) inhibitor therapy or within fourteen (14) days of stopping such treatment (see drug interactions section). it is also contraindicated in patients with severe hypertension, or severe coronary arter

ALLEGRA--D 24 HOUR- fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release Stati Uniti - Ingliż - NLM (National Library of Medicine)

allegra--d 24 hour- fexofenadine hydrochloride and pseudoephedrine hydrochloride tablet, film coated, extended release

physicians total care, inc. - fexofenadine hydrochloride (unii: 2s068b75zu) (fexofenadine - unii:e6582loh6v), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - fexofenadine hydrochloride 180 mg - allegra-d 24 hour extended-release tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years of age and older. symptoms treated effectively include sneezing, rhinorrhea, itchy nose/palate/ and/or throat, itchy/watery/red eyes, and nasal congestion. allegra-d 24 hour should be administered when both the antihistaminic properties of fexofenadine hydrochloride and the nasal decongestant properties of pseudoephedrine hydrochloride are desired (see clinical pharmacology). allegra-d 24 hour is contraindicated in patients with known hypersensitivity to any of its ingredients. due to its pseudoephedrine component, allegra-d 24 hour is contraindicated in patients with narrow-angle glaucoma or urinary retention, and in patients receiving monoamine oxidase (mao) inhibitor therapy or within fourteen (14) days of stopping such treatment (see drug interactions section). it is also contraindicated in patients with severe hypertension, or severe coronary arter

BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE syrup Stati Uniti - Ingliż - NLM (National Library of Medicine)

brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide syrup

par pharmaceutical - brompheniramine maleate (unii: ixa7c9zn03) (brompheniramine - unii:h57g17p2fn), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide syrup is indicated for relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold. hypersensitivity to any of the ingredients. do not use in the newborn, in premature infants, in nursing mothers, or in patients with severe hypertension or severe coronary artery disease. do not use dextromethorphan in patients receiving monoamine oxidase inhibitors (maoi) (see precautions - drug interactions ). antihistamines should not be used to treat lower respiratory tract conditions including asthma.

SUDOGEST- pseudoephedrine hydrochloride tablet Stati Uniti - Ingliż - NLM (National Library of Medicine)

sudogest- pseudoephedrine hydrochloride tablet

rebel distributors corp - pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - pseudoephedrine hydrochloride 30 mg - nasal decongestant - temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies, and nasal congestion associated with sinusitis - temporarily relieves sinus congestion and pressure

BROVEX PSB DM- pseudoephedrine hydrochloride, brompheniramine maleate, and dextromethorphan hydrobromide liquid Stati Uniti - Ingliż - NLM (National Library of Medicine)

brovex psb dm- pseudoephedrine hydrochloride, brompheniramine maleate, and dextromethorphan hydrobromide liquid

mcr american pharmaceuticals, inc. - pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), brompheniramine maleate (unii: ixa7c9zn03) (brompheniramine - unii:h57g17p2fn), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - pseudoephedrine hydrochloride 20 mg in 5 ml - temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other respiratory allergies: - runny nose - sneezing - itching of the nose or throat - itchy, watery eyes - cough due to minor throat and bronchial irritation - nasal congestion - reduces swelling of nasal passages

SUDAFED 12 HOUR- pseudoephedrine hydrochloride tablet, film coated, extended release Stati Uniti - Ingliż - NLM (National Library of Medicine)

sudafed 12 hour- pseudoephedrine hydrochloride tablet, film coated, extended release

johnson & johnson consumer inc., mcneil consumer healthcare division - pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - pseudoephedrine hydrochloride 120 mg - nasal decongestant - temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies - temporarily relieves sinus congestion and pressure

BROVEX PSB- pseudoephedrine hydrochloride and brompheniramine maleate liquid Stati Uniti - Ingliż - NLM (National Library of Medicine)

brovex psb- pseudoephedrine hydrochloride and brompheniramine maleate liquid

mcr american pharmaceuticals, inc. - pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), brompheniramine maleate (unii: ixa7c9zn03) (brompheniramine - unii:h57g17p2fn) - pseudoephedrine hydrochloride 20 mg in 5 ml - temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other respiratory allergies: - runny nose - sneezing - itching of the nose or throat - itchy, watery eyes - nasal congestion - reduces swelling of nasal passages

SUDAFED- pseudoephedrine hydrochloride tablet, coated Stati Uniti - Ingliż - NLM (National Library of Medicine)

sudafed- pseudoephedrine hydrochloride tablet, coated

johnson & johnson consumer inc., mcneil consumer healthcare division - pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f) - pseudoephedrine hydrochloride 30 mg - nasal decongestant - temporarily relieves sinus congestion and pressure - temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies

BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE- brompheniramine maleate, pseudoephedrine Stati Uniti - Ingliż - NLM (National Library of Medicine)

brompheniramine maleate, pseudoephedrine hydrochloride, dextromethorphan hydrobromide- brompheniramine maleate, pseudoephedrine

acella pharmaceuticals, llc - brompheniramine maleate (unii: ixa7c9zn03) (brompheniramine - unii:h57g17p2fn), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - brompheniramine maleate 2 mg in 5 ml - brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide syrup is indicated for relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold. hypersensitivity to any of the ingredients. do not use in the newborn, in premature infants, in nursing mothers, or in patients with severe hypertension or severe coronary artery disease. do not use dextromethorphan in patients receiving monoamine oxidase inhibitors (maois) (see drug interactions ). antihistamines should not be used to treat lower respiratory tract conditions including asthma.

BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE- brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide syrup Stati Uniti - Ingliż - NLM (National Library of Medicine)

brompheniramine maleate, pseudoephedrine hydrochloride, dextromethorphan hydrobromide- brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide syrup

preferred pharmaceuticals inc. - brompheniramine maleate (unii: ixa7c9zn03) (brompheniramine - unii:h57g17p2fn), pseudoephedrine hydrochloride (unii: 6v9v2ryj8n) (pseudoephedrine - unii:7cuc9ddi9f), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - brompheniramine maleate 2 mg in 5 ml - brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide syrup is indicated for relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold. hypersensitivity to any of the ingredients. do not use in the newborn, in premature infants, in nursing mothers, or in patients with severe hypertension or severe coronary artery disease. do not use dextromethorphan in patients receiving monoamine oxidase inhibitors (maois) (see drug interactions ). antihistamines should not be used to treat lower respiratory tract conditions including asthma.